Disparities in germline testing among racial minorities with prostate cancer

Volume: 25, Issue: 3, Pages: 403 - 410
Published: Nov 13, 2021
Abstract
Germline testing is becoming increasingly relevant in prostate cancer (PCa) screening, prognosis, and management. A subset of patients with PCa harbor pathogenic/likely pathogenic variants (P/LPVs) in genes mediating DNA-repair processes, and these P/LPVs have implications for cancer screening, treatment, and cascade testing. As a result, it is recommended that all men with high-risk localized and metastatic PCa undergo routine germline testing....
Paper Details
Title
Disparities in germline testing among racial minorities with prostate cancer
Published Date
Nov 13, 2021
Volume
25
Issue
3
Pages
403 - 410
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.